Jonathan Schulman
Jonathan Schulman

Jonathan Schulman

Partner

Denver | New York

303.291.2309
jonathan.schulman@ashurstperkins.com

Introduction

Jonathan advises public companies on , SEC disclosure obligations, corporate governance matters, and capital markets transactions.

Jonathan Schulman advises public companies on SEC reporting, compliance and disclosure issues, stock exchange rules, proxy advisory firm guidelines, stockholder activism, and general corporate matters.  

Jonathan also represents public companies and underwriters in a variety of capital markets transactions, including initial public offerings, underwritten equity and debt offerings, Rule 144A debt offerings, convertible note offerings, commercial paper programs, and private placements. He also counsels public companies in a variety of M&A transactions. 

Education & credentials

  • University of Virginia School of Law, J.D., Editorial Board, Virginia Law & Business Review, 2014
  • University of Miami, B.B.A., Entrepreneurship, summa cum laude, 2010
  • Colorado
  • New York
  • Latham & Watkins LLP, New York, NY and Washington, D.C., Associate, 2014-2018
  • Latham & Watkins LLP, New York, NY, Summer Associate, 2013

Professional recognition

  • Recognized by Best Lawyers: Ones to Watch for Corporate Law, 2024-2026

Amcor in over $5.5 billion of senior notes offerings

Amcor in its multibillion-dollar commercial paper programs

Crocs in $700 million of Rule 144A senior notes offerings

Crocs in a $244 million block trade of its common stock

MDU in its approximately $230 million follow-on offering of common stock with an equity forward

MDU in its up to $400 million ATM program with an equity forward

Pacira BioSciences in a $287.5 million Rule 144A offering of convertible senior notes

CAI International in multiple preferred stock and ATM offerings

Gevo in multiple follow-on common stock, warrant, and ATM offerings

Ideal Power in multiple follow-on offerings

The underwriters in multiple follow-on offerings of Fate Therapeutics

Representation of other various issuers and underwriters in connection with initial public offerings (IPOs), underwritten public offerings, at-the-market (ATM) offerings, private investment in public equity (PIPEs), private placements and other financing transactions

Crocs (Nasdaq: CROX) in its $2.5 billion acquisition of HEYDUDE

RadNet, Inc. (Nasdaq: RDNT) in its acquisition of iCAD, Inc. (Nadsaq: iCAD)

Pacira BioSciences (Nasdaq: PCRX) in its acquisition of Flexion Therapeutics (Nasdaq: FLXN)

Pacira BioSciences (Nasdaq: PCRX) in its acquisition of MyoScience

CAI International (NYSE: CAI) in its acquisition by Mitsubishi HC Capital

SMTC Corporation (Nasdaq: SMTX) in its acquisition by H.I.G. Capital

AeroGrow (OTC: AERO) in its acquisition by Scotts Miracle-Gro (NYSE: SMG)

Peak Resorts (Nasdaq: SKIS) in its acquisition by Vail Resorts (NYSE: MTN)

Jonathan provides ongoing public company representation to a number of public companies, including:

  • Crocs, Inc.
  • Everus Construction Group, Inc.
  • Knife River Corporation
  • MDU Resources Group, Inc.
  • Molson Coors Beverage Company
  • Pacira BioSciences, Inc.

Latest news, deals and awards

Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.